A2 Biotherapeutics, Inc. — Form D/A
A2 Biotherapeutics, Inc. of AGOURA HILLS, CA, a company, filed a Form D amendment with the SEC on 2020-10-26. The offering totals $71.5M, of which $71.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-10-26
- Form: D/A
- Accession: 0001828750-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $71.5M
- Amount sold: $71.5M
- Investors: 13
- Date of first sale: 2020-09-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-378361
Issuer
- Name: A2 Biotherapeutics, Inc.
- CIK: 0001828750
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 30301 AGOURA ROAD, #210, AGOURA HILLS, CA, 91301
- Phone: 805-491-1988
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Michael Gallo | Director | Agoura Hills, CA |
| C. Alexander Kamb | Director | Agoura Hills, CA |
| Helen S Kim | Director | Menlo Park, CA |
| Susan L Kelley | Director | San Diego, CA |
| Jakob S Loven | Director | New York, NY |
| Madhavan Balachandran | Director | Agoura Hills, CA |
| Scott Foraker | Director | Agoura Hills, CA |
| Scott Foraker | Executive Officer | Agoura Hills, CA |
| David S Lucas | Executive Officer | Agoura Hills, CA |
| Srini Akkaraju | Director | Agoura Hills, CA |
| William S Go | Executive Officer | Agoura Hills, CA |
| Thomas S Leung | Executive Officer | Agoura Hills, CA |
| Alexander Kamb | Director | Agoura Hills, CA |
| Alexander Kamb | Executive Officer | Agoura Hills, CA |
| David Goeddel | Director | Agoura Hills, CA |
Other filings by this issuer (3)
More